๐ต๏ธ Heartsciences Inc. ($HSCSW)
SEC insider & ownership activity, last 12 months ยท CIK 1468492 ยท every row links its SEC filing
Over the last 12 months insiders sold $16K with no open-market buying against it. Mark T. Hilz sold $16K in discretionary trades (Jul). No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) ยท 1 seller, $16K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark T. Hilz | 0 | โ | 1 | $16K | Jul 29, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ephraim G. Fields | 8.1% | 13G | Jun 24, 2026 | filing โ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 29, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing โ |
| Material agreement (1.01) | Jul 27, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 23, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jul 7, 2026 | filing โ |
| Officer/director changes (5.02) | Jul 7, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 7, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 23, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jun 22, 2026 | filing โ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing โ |
| Material agreement (1.01) | Jun 22, 2026 | filing โ |
| New financial obligation (2.03) | Jun 22, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jun 22, 2026 | filing โ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing โ |
| Shareholder vote (5.07) | Apr 30, 2026 | filing โ |
| Officer/director changes (5.02) | Apr 1, 2026 | filing โ |
| Earnings (2.02) | Mar 16, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Mar 16, 2026 | filing โ |
| Material agreement (1.01) | Jan 13, 2026 | filing โ |
| New financial obligation (2.03) | Jan 13, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jan 13, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing โ |
| Material agreement (1.01) | Dec 16, 2025 | filing โ |